CT Financial Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

CT Financial Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$472	Hold	80	–	–	﹤0.01%	610
2016 Q4	$432	Hold	80	–	–	﹤0.01%	610
2016 Q3	$712	Hold	80	–	–	﹤0.01%	599
2016 Q2	$769	Hold	80	–	–	﹤0.01%	593
2016 Q1	$736	Hold	80	–	–	﹤0.01%	590
2015 Q4	$1.01K	Hold	80	–	–	﹤0.01%	583
2015 Q3	$968	Hold	80	–	–	﹤0.01%	601
2015 Q2	$1.39K	Hold	80	–	–	﹤0.01%	579
2015 Q1	$1.16K	Hold	80	–	–	﹤0.01%	579
2014 Q4	$672	Buy	+80	New	+$732	﹤0.01%	492
2014 Q1	$1.16K	Buy	+80	New	+$1.44K	﹤0.01%	579

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CT Financial Advisors's AVEO Position: Q1 2017 in Review

CT Financial Advisors held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q1 2017 at 80 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #610.

CT Financial Advisors first reported a position in AVEO in Q1 2014 and has held it in 11 quarters since. The position peaked at $1.39K in Q2 2015. 49 funds tracked by Wall St. Rank hold AVEO as of Q1 2017.

CT Financial Advisors held 80 shares of AVEO Pharmaceuticals, Inc. worth $472 as of Q1 2017.
CT Financial Advisors left its AVEO Pharmaceuticals, Inc. share count unchanged in Q1 2017.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #610 holding.
CT Financial Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's AVEO Pharmaceuticals, Inc. position peaked at $1.39K in Q2 2015.
49 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.